Does BUROSUMAB-TWZA Cause Injection site erythema? 122 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Injection site erythema have been filed in association with BUROSUMAB-TWZA. This represents 2.4% of all adverse event reports for BUROSUMAB-TWZA.
122
Reports of Injection site erythema with BUROSUMAB-TWZA
2.4%
of all BUROSUMAB-TWZA reports
0
Deaths
1
Hospitalizations
How Dangerous Is Injection site erythema From BUROSUMAB-TWZA?
Of the 122 reports, 1 (0.8%) required hospitalization.
Is Injection site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BUROSUMAB-TWZA. However, 122 reports have been filed with the FAERS database.
What Other Side Effects Does BUROSUMAB-TWZA Cause?
Inappropriate schedule of product administration (579)
Blood phosphorus decreased (509)
Product dose omission issue (475)
Arthralgia (285)
Pain (279)
Pain in extremity (272)
Headache (226)
Restless legs syndrome (217)
Incorrect dose administered (215)
Injection site pain (205)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which BUROSUMAB-TWZA Alternatives Have Lower Injection site erythema Risk?
BUROSUMAB-TWZA vs BUSPIRONE
BUROSUMAB-TWZA vs BUSULFAN
BUROSUMAB-TWZA vs BUSULFEX
BUROSUMAB-TWZA vs BUTALBITAL
BUROSUMAB-TWZA vs BUTENAFINE